Publisher： Bentham Science Publishers
E-ISSN： 1875-6638|3|3|301-316
ISSN： 1573-4064
Source： Medicinal Chemistry, Vol.3, Iss.3, 2007-05, pp. : 301-316
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The last 10 years have seen resurgent industry activity in discovery and development of new drugs for the treatment of tuberculosis (TB), a growing widespread and devastating (more than 2 million deaths annually) bacterial infection that is of increasing concern in developing and developed nations alike. This review describes drugs currently being evaluated in the clinic for treatment of uncomplicated and drug resistant pulmonary TB, and updates the literature on 5 new drugs that entered clinical trials in the last 4 years.
Related content
Access to resources
Recommend
By Grassi C.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. :
New Tuberculosis Drugs in Development
Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. :